BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mocan-Hognogi DL, Trancǎ S, Farcaş AD, Mocan-Hognogi RF, Pârvu AV, Bojan AS. Immune Checkpoint Inhibitors and the Heart. Front Cardiovasc Med 2021;8:726426. [PMID: 34660728 DOI: 10.3389/fcvm.2021.726426] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Du Y, Wu T. Heart failure and cancer: From active exposure to passive adaption. Front Cardiovasc Med 2022;9:992011. [PMID: 36304546 DOI: 10.3389/fcvm.2022.992011] [Reference Citation Analysis]
2 Ganesh S, Zhong P, Zhou X. Cardiotoxicity induced by immune checkpoint inhibitor: The complete insight into mechanisms, monitoring, diagnosis, and treatment. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.997660] [Reference Citation Analysis]
3 Dong M, Yu T, Zhang Z, Zhang J, Wang R, Tse G, Liu T, Zhong L. ICIs-Related Cardiotoxicity in Different Types of Cancer. JCDD 2022;9:203. [DOI: 10.3390/jcdd9070203] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]